OBJECTIVE： To review the practicality and effectiveness of “Ready-to-use” extended mobile Baxter intravenous admixture service （BIVAS） in the application of intravenous medication centralized deployment services. METHODS： Combined with the requirements of Intravenous Admixture Centralized Deployment and Quality Management Practices， and the present establishment and management characteristics in pharmacy intravenous admixture services （PIVAS） in our hospital， the development and management methods of BIVAS each link were introduced and summarized from pre-building to post-trial operation. RESULTS & CONCLUSIONS： Specific measures and methods for developing BIVAS in our hospital were introduced from aspects of assessment， site selection， building， research， staffing and operation， etc. It had proved that BIVAS can achieve a daily compounding load of about 600 bags in 8 wards of eastern branch of our hospital. Since BIVAS holds advantages in sterile dispensing equipment and technology that is comparable to PIVAS， and lower space requirements， shorter building periods， more flexible combination， less occupation of funds and other health resources as well as more convenient post-maintenance， it can take the place of PIVAS to effectively complete intravenous drug deployment services under general workload with certain practicality when a hospital couldn’t build PIVAS limited by building funds， venues， time and other factors.